Drugs and Devices
by Jenna Ogilvie | Apr 19, 2021 | Commentary, Perspectives
In 2021, as the majority of the world’s population eagerly waits to receive safe and effective COVID-19 vaccines, factories worldwide are producing bits of the vaccine components—mRNA, lipids, proteins, key reagents, and attenuated viruses—and then assembling...
by Jenna Ogilvie | Nov 30, 2020 | Discussion Paper, Perspectives
The health care ecosystem is witnessing a surge of artificial intelligence (AI)-driven technologies and products that can potentially augment care delivery outside of hospital and clinic settings. These tools can be used to conduct remote monitoring, support...
by Jenna Ogilvie | Jul 27, 2020 | Commentary, Perspectives
When my brother told me he had been diagnosed with COVID-19, I was scared. My memory immediately jumped to visions of his childhood struggles with asthma, which he described as having an ever-tightening chain around his chest. I thought of intubated COVID-19...
by Jenna Ogilvie | Oct 28, 2019 | Commentary, Perspectives
Introduction One-third of the US population has health literacy levels that are basic or below basic [1]. This statistic, while surprising, is not unique to the United States: limited health literacy impacts access to appropriate health-related services around...
by Jenna Ogilvie | Sep 30, 2019 | Discussion Paper, Perspectives
Introduction Cell-, gene-, and tissue-based advanced therapeutic products, referred to in this paper as “cell and gene therapy” (CGT) products, have the potential to address many unmet medical needs. These products are commonly discovered and developed in...
Page 1 of 812345...»Last »
